Predatory Journals on Trial: ALLEGATIONS, RESPONSES, AND LESSONS FOR SCHOLARLY PUBLISHING FROM FTC V. OMICS
Predatory Journals on Trial: ALLEGATIONS, RESPONSES, AND LESSONS FOR SCHOLARLY PUBLISHING FROM FTC V. OMICS
复制标题
DOI：
10.3138/jsp.50.3.02
复制
发表时间：
2019-04-01
影响因子：
1.3
通讯作者：
Manley, Stewart
中科院分区：
文献类型：
--
作者：
Manley, Stewart
2016 年 8 月 25 日，美国联邦贸易委员会 (FTC) 起诉 OMICS Group Inc.、iMedPub LLC、Conference Series LLC 和 Srinubabu Gedela，这些公司均隶属于开放获取大型出版商 OMICS International，指控其在征集期刊文章和会议广告方面存在欺骗行为。正在进行的诉讼旨在制止 OMICS 的欺骗行为并归还 5,050 万美元的非法所得。 OMICS 因该诉讼对其业务和员工造成的损失索赔超过 21 亿美元。本文介绍了截至 2018 年 10 月 14 日提交的 5920 页诉状、证据和命令中的主要论点、反论点和法院判决。然后文章评估了该案件，为出版商、编辑、学者和大学制定了关键要点。根据其最终结果，针对 OMICS 的案件可能会成为有问题的开放获取在线出版商实践的转折点，使这一临时案件评估与所有关心学术出版未来的人相关。
On 25 August 2016, the US Federal Trade Commission (FTC) sued OMICS Group Inc., iMedPub LLC, Conference Series LLC, and Srinubabu Gedela, all affiliated with open access mega-publisher OMICS International, for deception in their solicitation of journal articles and advertising of conferences. The ongoing lawsuit seeks to stop OMICS's deceptive practices and disgorge US $50.5 million in ill-gotten gains. OMICS has in turn claimed over $2.1 billion for harm caused by the lawsuit to its business and employees. This article describes the main arguments, counter-arguments, and court decisions in the 5920 pages of pleadings, exhibits, and orders that have been filed through 14 October 2018. The article then evaluates the case to formulate key take-aways for publishers, editors, academics, and universities. Depending on its ultimate outcome, the case against OMICS may be a turning point in the practices of questionable open access online publishers, making this interim case assessment pertinent to all concerned about the future of academic publishing.